Ivabradine improves systolic ejection time in heart failure with reduced ejection fraction by heart rate-dependent and -independent mechanisms - results from the SHIfT echocardiography substudy
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in heart failure patients with mid-range and preserved ejection fraction and clinical outcomes: from the KCHF Registry